Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001415889-24-002612 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-05 | 2024-02-01 | PCVX | Wassil Jim | COO | S - Sale+OE | $73.88 | -3,000 | 177.4K | -2% | -$221.6K |
| D | 2024-02-05 | 2024-02-01 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +3,000 | 178.9K | +2% | +$7,260 |
| D | 2024-02-05 | 2024-02-01 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -3,000 | 90.6K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | S | D | 527 | $72.18 | 178,408 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $71.69 to $72.51. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-02-01 | S | D | 950 | $75.28 | 175,935 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $74.80 to $75.69. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-02-01 | S | D | 467 | $74.14 | 176,885 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $73.77 to $74.765. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-02-01 | S | D | 1,056 | $73.35 | 177,352 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $72.71 to $73.69. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-02-01 | M | A | 3,000 | $2.42 | 178,935 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2024-02-01 | M | D | 3,000 | $0.00 | 90,555 | D | $2.42 · — to 2029-12-16 | 3,000 Common Stock | (F6) 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter. |